The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in metastatic castration-resistant prostate cancer (mCRPC) pts receiving a new agent (NA)- based third line treatment: Final results from a multicenter Italian study.
 
Orazio Caffo
Honoraria - Astellas Pharma; Bayer; Janssen Oncology; Sanofi
 
Emilio Bria
No Relationships to Disclose
 
Ugo De Giorgi
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Pfizer; Pierre Fabre; Sanofi
 
Marcello Tucci
No Relationships to Disclose
 
Elisa Biasco
No Relationships to Disclose
 
Lucia Fratino
No Relationships to Disclose
 
Gaetano Facchini
No Relationships to Disclose
 
Roberto Iacovelli
No Relationships to Disclose
 
Giovanni Lo Re
No Relationships to Disclose
 
Simone Scagnoli
No Relationships to Disclose
 
Franco Morelli
No Relationships to Disclose
 
Alessandro D'Angelo
No Relationships to Disclose
 
Francesco Verderame
No Relationships to Disclose
 
Enrico Campadelli
No Relationships to Disclose
 
Riccardo Ricotta
No Relationships to Disclose
 
Martina Napolitano
No Relationships to Disclose
 
Donata Sartori
No Relationships to Disclose
 
Nicolo Borsellino
No Relationships to Disclose
 
Isabella Sperduti
No Relationships to Disclose
 
Marco Maruzzo
No Relationships to Disclose